TransMedics
TransMedics Receives FDA PMA Approval of OCS™ DCD Heart Indication | TransMedics
ANDOVER, Mass. , April 28, 2022 /PRNewswire/ -- TransMedics Group, Inc. (" TransMedics ") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that the U.S.